Staphylococcus aureus in Inflammatory Bowel Disease

References

• Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811–3.
   PubMed Web of Science ®Google Scholar
• Mollick JA, Cook RG, Rich RR. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science 1989;244:817–20.
   Google Scholar
• Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705–11.
   PubMed Web of Science ®Google Scholar
• Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325–9.
   PubMed Web of Science ®Google Scholar
• Abe J, Kotzin BL, Jujo K, Melish M, Glode MP, Kohsaka T, et al. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 1992;89:4066–70.
   PubMed Web of Science ®Google Scholar
• Abe J, Takeda T, Watanabe Y, Nakao H, Kobayashi N, Leung DYM, et al. Evidence for superantigen production by Yersinia pseudotuberculosis . J Immunol 1993;151:4183–8.
   PubMed Web of Science ®Google Scholar
• Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371:351–5.
   PubMed Web of Science ®Google Scholar
• Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995;16:145–9.
   Google Scholar
• Ibbotson JP, Lowes JR. Potential role of superantigen inducedactivation of cell mediated immune mechanisms in the pathogenesis of Crohn’s disease. Gut 1995;36:1–4.
   PubMedGoogle Scholar
• Sartor RB. Enteric microflora in IBD: pathogens or commensals? Inflam Bowel Dis 1997;3:230–5.
   PubMed Web of Science ®Google Scholar
• Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. T cell antigen receptor V gene usage. Increases in Vβ8+ T cells in Crohn’s disease. J Clin Invest 1990;85:1770–6.
   PubMed Web of Science ®Google Scholar
• Morson BC. Pathology of Crohn’s disease. Clin Gastroenterol 1972;1:265–77.
   Google Scholar
• Rickert RR, Carter HW. The ‘early’ ulcerative lesion of Crohn’s disease: correlative light- and scanning electron-microscopic studies. J Clin Gastroenterol 1980;2:11–9.
   PubMed Web of Science ®Google Scholar
• Chiba M, Komatsu M, Iizuka M, Masamune O, Hoshina S, Kono M. Microbiology of the intestinal lymph follicle—a clue to elucidate causative microbial agent(s) in Crohn’s disease. Med Hypotheses 1998;51:421–7.
   PubMed Web of Science ®Google Scholar
• Chiba M, Kono M, Hoshina S, Komatsu M, Kitagawa Y, Iizuka M, et al. Presence of bacterial 16S ribosomal RNA gene segments in human intestinal lymph follicles. Scand J Gastroenterol 2000;35:824–31.
   PubMed Web of Science ®Google Scholar
• Cashman JS, Smith CB, Weidner M, Matsen JM. Evaluation of cost-effectiveness and rationale for use of a selective culture plate for isolation of Staphylococcus aureus from stool specimens. J Clin Microbiol 1984;20:570–1.
   PubMedGoogle Scholar
• Abe J, Takazoe M, Matsumoto T, Tatewaki M, Hoshino E. Possible role of bacterial superantigens in the pathogenesis of Crohn’s disease. Annual report of the Research Committee of Inflammatory Bowel Disease, The Ministry of Health and Welfare of Japan; 1999. p. 79–81 (in Japanese with English abstract).
   Google Scholar
• Aisenberg J, Ebert EC, Mayer L. T cell activation in human intestinal mucosa: the role of superantigens. Gastroenterology 1993;105:1421–30.
   Google Scholar
• Lionetti P, Spencer J, Breese EJ, Murch SH, Taylor J, MacDonald TT. Activation of mucosal Vβ3+ cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol 1993;23: 664–8.
   PubMedGoogle Scholar
• Goh S-H, Byrne SK, Zhang JL, Chow AW. Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol 1992;30: 1642–5.
   PubMed Web of Science ®Google Scholar
• Liu Y, Van Kruiningen J, Brian West A, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease. Gastroenterology 1995;108:1396–404.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Miller RA, Lacher J, Singleton JW. Patients with active Crohn’s disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984;87:888–94.
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Mori K. Aphthoid colitis. Stomach Intestine 1976;11:793–801 (in Japanese with English abstract).
   Google Scholar
• Chiba M, Suzuki T, Horie Y, Masamune O. An unusual form of aphthoid proctocolitis. Dig Endosc 1994;6:258–64.
   Google Scholar
• Franken EA. Lymphoid hyperplasia of the colon. Radiology 1970;94:329–34.
   PubMed Web of Science ®Google Scholar
• Chiba M, Iizuka M, Ishii N, Masamune O. Crohn’s disease associated with diffuse lymphoid hyperplasia of the large intestine: a possible role of the lymph follicle in HLA-DR antigen expression on epithelium. Intern Med 1992;31:1271–6.
   PubMedGoogle Scholar
• Myren J, Bouchier IAD, Watkinson G, Softley A, Clamp SE, de Dombal FT. The O.M.G.E. multinational inflammatory bowel disease survey 1976–1982. A further report on 2,657 cases. Scand J Gastroenterol 1984;19 Suppl 95: 1–27.
   Google Scholar
• Hiwatashi N. A revised guideline of therapy for Crohn’s disease. Annual report of the Research Committee of Inflammatory Bowel Disease, the Ministry of Health and Welfare of Japan; 1998. p. 216–7 (in Japanese).
   Google Scholar
• Chiba M, Iizuka M, Ohtaka M, Kuwabara T, Masmune O, Mukoujima T, et al. Four cases of the red ring sign. Gastrointest Endosc 1992;38:728–30.
   PubMed Web of Science ®Google Scholar
• Kudo T, Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. Analysis of the lymph follicles of Crohn’s disease by acetic acid fixation of the intestine. Akita J Med 1996;23:105–14 (in Japanese with English abstract).
   Google Scholar
• Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer’s patches and lymph follicles, of Crohn’s disease. J Gastroenterol 1998;33: 482–7.
   Google Scholar
• Chiba M, Fukushima T, Inoue S, Horie Y, Iizuka M, Masamune O. Listeria monocytogenes in Crohn’s disease. Scand J Gastroenterol 1998;33:430–4.
   PubMedGoogle Scholar
• Tobita M, Urayama O, Uesugi S. Restriction fragment length polymorphism of coagulase gene of Methicillin-resistant Staphylococcus aureus can be used as an epidemiological marker. J Jpn Assoc Infect Dis 1995;69:408–12 (in Japanese with English abstract).
   Google Scholar
• Warsa UC, Okubo T, Okamoto R. Antimicrobial susceptibilities and phage typing of Staphylococcus aureus clinical isolates in Indonesia. J Infect Chemother 1996;2:29–33.
   Google Scholar
• Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of Staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240–4.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;II:1067–88.
   Google Scholar
• Shalon L, Gulwani-Akolkar B, Fisher SE, Akolkar PN, Panja A, Mayer L, et al. Evidence for an altered T-cell receptor repertoire in Crohn’s disease. Autoimmunity 1994;17:301–7.
   PubMed Web of Science ®Google Scholar
• Lugering N, Kucharzik T, Fisahn M, Domschke W, Stoll R. Crohn’s disease (CD) patients suffering from peripheral arthritis or ankylosing spondylitis reveal restricted T cell receptor Vβ regions in different temporal phases of disease. Clin Exp Immunol 1996;105:278–84.
   Google Scholar
• Ogawa H, Ito H, Takeda A, Kanazawa S, Yamamoto M, Nakamura H, et al. Universal skew of T cell receptor (TCR) Vβ usage for Crohn’s disease (CrD). Biochem Biophys Res Commun 1997;240:545–51.
   PubMedGoogle Scholar
• Watanabe M, Hayashi A, Hosoda Y, Ohara M, Iwao Y, Ishii H, et al. Preferential activation of CD4+Vβ 5.2/5.3⁺ intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn’s disease. Clin Immunol Immunopathol 1996;78:130–9.
   Google Scholar
• Chiba M, Iizuka M, Horie Y, Ishii N, Masamune O. Expression of HLA-DR antigens on colonic epithelium around lymph follicles. An anomalous expression in Crohn’s disease. Dig Dis Sci 1994;39:83–90.
   Google Scholar
• Cooper HS, Raffensperger EC, Jonas L, Fitts WT. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilatation requiring colonic resection. Gastroenterology 1977; 72:1253–6.
   PubMed Web of Science ®Google Scholar
• Sidi S, Graham JH, Razvi SA, Banks PA. Cytomegalovirus infection of the colon associated with ulcerative colitis. Arch Surg 1979;114:857–9.
   PubMedGoogle Scholar
• Lindeman RJ, Weinstein L, Levitan R, Patterson JF. Ulcerative colitis and intestinal salmonellosis. Am J Med Sci 1967;254: 855–61.
   PubMed Web of Science ®Google Scholar
• Goodman MJ, Pearson KW, McGhie D, Dutt S, Deodhar SG. Campylobacter and giardia lamblia causing exacerbation of inflammatory bowel disease. Lancet 1980 ii:1247.
   Google Scholar
• Newman A, Lambert JR. Campylobacter jejuni causing flare-up in inflammatory bowel disease. Lancet 1980;ii:919.
   Google Scholar
• Trnka YM, Lamont JT. Association of clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology 1981;80:693–6.
   PubMed Web of Science ®Google Scholar
• Chiba M, Fukushima T, Koganei K, Nakamura N, Masamune O. Listeria monocytogenes in the colon in a case of fulminant ulcerative colitis. Scand J Gastroenterol 1998;33:778–82.
   Google Scholar